Inventor · disambiguated record
Roman Yelensky
Also filed as: YELENSKY ROMAN
31 granted patents·48 pending applications·399 citations·filing 2011–2025
97Inventor score
Files withFOUND MEDICINE INC29GRITSTONE BIO INC24GRITSTONE ONCOLOGY INC12GENENTECH INC5FOUNDATION MEDICINE INC2
Top patents by PatentIndex Score
79 records- 0196US12180540B2Optimization of multigene analysis of tumor samplesFOUND MEDICINE INC·Filed 2022·Granted Dec 31, 2024·2 cites·20 claims
- 0295US9340830B2Optimization of multigene analysis of tumor samplesLIPSON DORON·Filed 2011·Granted May 17, 2016·256 cites·85 claims
- 0394US11098368B2ALK and NTRK1 fusion molecules and uses thereofFOUND MEDICINE INC·Filed 2018·Granted Aug 24, 2021·5 cites·30 claims
- 0494US10000814B2ALK and NTRK1 fusion molecules and uses thereofFOUND MEDICINE INC·Filed 2014·Granted Jun 19, 2018·12 cites·37 claims
- 0593US11183286B2Neoantigen identification, manufacture, and useGRITSTONE BIO INC·Filed 2020·Granted Nov 23, 2021·3 cites·30 claims
- 0693US9907798B2Methods of treating head and neck cancerFOUND MEDICINE INC·Filed 2016·Granted Mar 6, 2018·7 cites·22 claims
- 0792US11136619B2Optimization of multigene analysis of tumor samplesFOUND MEDICINE INC·Filed 2018·Granted Oct 5, 2021·5 cites·20 claims
- 0892US11118213B2Optimization of multigene analysis of tumor samplesFOUND MEDICINE INC·Filed 2018·Granted Sep 14, 2021·6 cites·21 claims
- 0991US11421265B2Optimization of multigene analysis of tumor samplesFOUND MEDICINE INC·Filed 2019·Granted Aug 23, 2022·4 cites·19 claims
- 1091US11279767B2Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2018·Granted Mar 22, 2022·7 cites·11 claims
- 1191US10055540B2Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2017·Granted Aug 21, 2018·21 cites·25 claims
- 1291US9792403B2Analysis of genetic variantsSUN JAMES XIN·Filed 2014·Granted Oct 17, 2017·35 cites·22 claims
- 1391US9410954B2Human papilloma virus as predictor of cancer prognosisFOUND MEDICINE INC·Filed 2014·Granted Aug 9, 2016·8 cites·25 claims
- 1490US11300570B2Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2019·Granted Apr 12, 2022·3 cites·18 claims
- 1590US10847249B2Analysis of genetic variantsFOUND MEDICINE INC·Filed 2017·Granted Nov 24, 2020·6 cites·30 claims
- 1690US2025146077A1Novel estrogen receptor mutations and uses thereofFOUND MEDICINE INC·Filed 2024·Application pending·0 cites
- 1790US2025154563A1Optimization of multigene analysis of tumor samplesFOUND MEDICINE INC·Filed 2024·Application pending·0 cites
- 1889US11230589B2Fusion molecules and uses thereofFOUND MEDICINE INC·Filed 2013·Granted Jan 25, 2022·7 cites·26 claims
- 1988US11771747B2Multiepitope vaccine cassettesGRITSTONE BIO INC·Filed 2022·Granted Oct 3, 2023·2 cites·23 claims
- 2088US8673972B2Human papilloma virus as predictor of cancer prognosisFOUNDATION MEDICINE INC·Filed 2013·Granted Mar 18, 2014·5 cites·20 claims
- 2187US2024360199A1Novel fusion molecules and uses thereofFOUND MEDICINE INC·Filed 2024·Application pending·0 cites
- 2286US11286532B2Estrogen receptor mutations and uses thereofFOUND MEDICINE INC·Filed 2018·Granted Mar 29, 2022·1 cites·15 claims
- 2386US2025340615A1Novel fusion molecules and uses thereofFOUND MEDICINE INC·Filed 2025·Application pending·0 cites
- 2486US2025333479A1Novel fusion molecules and uses thereofFOUND MEDICINE INC·Filed 2025·Application pending·0 cites
- 2586US2025333480A1Fusion molecules and uses thereofFOUND MEDICINE INC·Filed 2025·Application pending·0 cites
- 2685US11058687B2Human papilloma virus as predictor of cancer prognosisFOUND MEDICINE INC·Filed 2019·Granted Jul 13, 2021·1 cites·49 claims
- 2781US12116638B2Estrogen receptor mutations and uses thereofFOUND MEDICINE INC·Filed 2022·Granted Oct 15, 2024·0 cites·25 claims
- 2881US11264117B2Neoantigen identification using hotspotsGRITSTONE BIO INC·Filed 2019·Granted Mar 1, 2022·2 cites·29 claims
- 2979US10093983B2Estrogen receptor mutations and uses thereofFOUND MEDICINE INC·Filed 2015·Granted Oct 9, 2018·1 cites·26 claims
- 3078US12378302B2Fusion molecules and uses thereofFOUND MEDICINE INC·Filed 2021·Granted Aug 5, 2025·0 cites·10 claims
- 3176US11766439B2Human papilloma virus as predictor of cancer prognosisFOUND MEDICINE INC·Filed 2021·Granted Sep 26, 2023·0 cites·18 claims
- 3276US2025306027A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2025·Application pending·0 cites
- 3374US12456541B2Analysis of genetic variantsFOUND MEDICINE INC·Filed 2020·Granted Oct 28, 2025·0 cites·30 claims
- 3474US2022412981A1Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2022·Application pending·0 cites
- 3573US2024361335A1Reducing junction epitope presentation for neoantigensGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 3673US2019233897A1Novel estrogen receptor mutations and uses thereofFOUND MEDICINE INC·Filed 2018·Application pending·0 cites
- 3771US12331128B2Therapeutic and diagnostic methods for cancerGENENTECH INC·Filed 2022·Granted Jun 17, 2025·0 cites·13 claims
- 3871US2024067985A1Viral delivery of neoantigensGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 3970US2014221329A1Novel estrogen receptor mutations and uses thereofFOUNDATION MEDICINE INC·Filed 2014·Application pending·0 cites
- 4069US2025353914A1Antigen-binding proteins and related methods of useGRITSTONE BIO INC·Filed 2025·Application pending·0 cites
- 4169US2025316334A1Neoantigen identification, manufacture, and useGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 4269US2023128001A1Hiv antigens and mhc complexesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 4368US2023382997A1Antigen-binding proteins targeting shared antigensGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 4468US2025270589A1Viral delivery of neoantigensSEATTLE PROJECT CORP·Filed 2025·Application pending·0 cites
- 4568US2018338977A1Human papilloma virus as predictor of cancer prognosisFOUND MEDICINE INC·Filed 2018·Application pending·0 cites
- 4667US2024285739A1Multiepitope vaccine cassettesGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 4766US10847253B2Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2018·Granted Nov 24, 2020·0 cites·30 claims
- 4866US2017016073A1Novel estrogen receptor mutations and uses thereofFOUND MEDICINE INC·Filed 2016·Application pending·0 cites
- 4966US2022148681A1Neoantigen identification using hotspotsGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 5065US10847252B2Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2018·Granted Nov 24, 2020·0 cites·31 claims
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Roman Yelensky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →